World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02517281
Date of registration: 07/02/2014
Prospective Registration: No
Primary sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Public title: Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies SKINTARGET
Scientific title: Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies
Date of first enrolment: July 12, 2011
Target sample size: 700
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02517281
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Caroline Robert, MD
Address: 
Telephone: 0142114210
Email: caroline.robert@gustaveroussy.fr
Affiliation: 
Name:     Caroline Robert, MD
Address: 
Telephone: 0142114210
Email: caroline.robert@gustaveroussy.fr
Affiliation: 
Name:     Caroline Robert, MD
Address: 
Telephone:
Email:
Affiliation:  Gustave Roussy, Cancer Campus, Grand Paris
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with cancer beginning a targeted therapy

- Patients able to follow the protocol

- Age >/= 18 years old

- Signed inform consent

Exclusion Criteria:

- Patient unable to follow the protocol, having a non cooperative behavior or unable to
come to follow up visits or unable to complete the study

- Pregnant or breastfeeding woman



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Cancer
Intervention(s)
Procedure: Biopsy
Primary Outcome(s)
Number of clinical secondary effects bind to targeted therapies [Time Frame: Every 28 days up to 5 years]
Secondary Outcome(s)
Secondary ID(s)
2010-A01052-37
2010/1664
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history